Indolent lymphoma is a chronic, slow-growing form of non-Hodgkin lymphoma, often called low-grade lymphoma. According to the American Cancer Society, this type of lymphoma accounts for 41% of all non-Hodgkin lymphoma cases in North America and Northern Europe. Although due to its slow growth, many patients may not have obvious symptoms when first diagnosed and therefore may not require immediate treatment, this does not mean that we can ignore these hidden warning signs. Initial findings in many patients include painless lymph node swelling and unexplained weight loss, which may be important indicators of disease progression.
Patients usually present with swollen lymph nodes in the neck, armpit, or groin, and in some cases, internal lymph nodes such as the chest or abdomen may also be swollen, which requires early examination.
The symptoms of indolent lymphoma are often subtle, which is why it is dangerous. By the time patients notice painless lymph node swelling, they are often already in the early stages of the disease. In addition, symptoms such as unexplained fever, significant weight loss, or night sweats may alert patients to seek further medical advice.
Age is an obvious risk factor. The risk of developing indolent lymphoma gradually increases with age.
Research shows that the incidence of indolent lymphoma is closely related to age, and is especially more common in those over 70 years old. In addition to age, people associated with HIV infection are also at a relatively higher risk of developing indolent lymphoma. In addition, individuals with first-generation cases in their families and those with chronic hepatitis C infection are all high-risk groups for this disease.
Diagnosis of indolent lymphoma usually involves a detailed history, physical examination, and various tests, such as blood tests, bone marrow biopsies, or imaging studies. Early detection of this disease is crucial to treatment, especially at the stage when a painful lump is present or not.
Sometimes, delayed diagnosis may worsen the condition and make future treatment more difficult.
Because indolent lymphoma progresses slowly, not all patients need to start treatment immediately after diagnosis. Instead, some patients may be advised to watch and wait until their condition worsens before starting treatment. Common treatment options include radiation therapy and chemotherapy, and some patients may receive targeted therapy or immunotherapy.
Although indolent lymphoma is difficult to treat, many patients survive for many years, which causes many people to have misconceptions about this disease.
According to the latest data, the five-year survival rate of this type of lymphoma exceeds 88%. Especially for young patients, the prognosis is even more promising, but again, it all depends on early recognition and timely treatment.
Facing the growing health threat of indolent lymphoma, we need to be more sensitive to changes in the body. Prevention is always the most important thing, and recognizing symptoms early and seeking professional medical advice can be life-changing. Have you ignored these possible warning signs, and how can you take better care of yourself now?